Oppenheimer Reiterates Outperform Rating on Viking Therapeutic (VKTX)

September 21, 2026 5:11 AM

Oppenheimer analyst Jay Olson reiterated an Outperform rating and $100.00 price target on Viking Therapeutic (NASDAQ: VKTX).The analyst comments "We ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found